/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR-B) today announces that an e-poster entitled "Liver biopsy biomarkers in a phase 1 study of the prodrug.
/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR-B) today announced that the World Health Organization (WHO) has selected the International Nonproprietary.
/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR-B) today announced that the World Health Organization (WHO) has selected the International Nonproprietary.
/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR) today announced that Jens Lindberg will assume his position as CEO on January 24, 2022. Magnus Christensen,.
/PRNewswire/ Medivir AB (Nasdaq Stockholm: MVIR) today announced that Jens Lindberg will assume his position as CEO on January 24, 2022. Magnus Christensen,.